Sitemap > Breaking Research > Diagnostics & Devices
Displaying 351 - 400 of 1058 results
- Psychometric properties of the Beck Depression Inventory-Second Edition (BDI-II) in individuals with chronic pain.
- Establishment of hybrid cell lines producing monoclonal antibodies to a synthetic Peptide from the e1 region of the hepatitis C virus.
- Rapid and simple detection of a mycobacterium circulating antigen in serum of pulmonary tuberculosis patients by using a monoclonal antibody and Fast-Dot-ELISA.
- Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report.
- Use of a SQUID array to detect T-cells with magnetic nanoparticles in determining transplant rejection.
- A novel porous collagen scaffold around an implantable biosensor for improving biocompatibility. I. In vitro/in vivo stability of the scaffold and in vitro sensitivity of the glucose sensor with scaffold.
- Diagnostic Accuracy Study of Urine Dipstick in Relation to 24-Hour Measurement as a Screening Tool for Proteinuria in Lupus Nephritis.
- Glycopolydiacetylene nanoparticles as a chromatic biosensor to detect Shiga-like toxin producing Escherichia coli O157:H7.
- Balancing Efficacy and Safety of Drug-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention.
- Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival.
- Direct acoustic profiling of DNA hybridisation using HSV type 1 viral sequences.
- Enzyme-catalyzed signal amplification for electrochemical DNA detection with a PNA-modified electrode.
- Predicting patients at high-risk of systemic reactions to cluster allergen immunotherapy: a pilot prospective observational study.
- Semi-mechanistic description of the in-vitro antiproliferative effect of different antitumour agents.
- Pretransplant Donor-Specific Interferon-gamma ELISPOT Assay Predicts Acute Rejection Episodes in Renal Transplant Recipients.
- Could BNP screening of acute chest pain cases lead to safe earlier discharge of patients with non-cardiac causes? A pilot study.
- Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer.
- The role of imaging in the detection of prostate cancer local recurrence after radiation therapy and surgery.
- NQO1 Expression in Pancreatic Cancer and Its Potential Use as a Biomarker.
- Assessment of two automated imaging systems in evaluating estrogen receptor status in breast carcinoma.
- In vivo bioluminescence visualization of antitumor effects by human MUC1 vaccination.
- Detection of non-ST-elevation myocardial infarction and unstable angina in the acute setting: meta-analysis of diagnostic performance of multi- detector domputed tomographic angiography.
- Multiplex real-time PCR for detection of respiratory tract infections.
- The eap Gene as a Novel Target for Specific Identification of Staphylococcus aureus.
- An immunological method for the detection of BCR-ABL fusion protein and monitoring its activation.
- A Differential Diagnostic Model of Diabetic Nephropathy and Non-Diabetic Renal Diseases.
- Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis.
- Role of FDG-PET in the Assessment of Survival Prognosis in Melanoma.
- Evaluation of [(11)C]rofecoxib as PET tracer for cyclooxygenase 2 overexpression in rat models of inflammation.
- (R)-N-Methyl-3-(3-(125)I-pyridin-2-yloxy)-3-phenylpropan-1-amine: a novel probe for norepinephrine transporters.
- Synthesis, radiolabeling and baboon SPECT imaging of 2beta-carbomethoxy-3beta-(3'-[(123)I]iodophenyl)tropane ([(123)I]YP256) as a serotonin transporter radiotracer.
- Feasibility studies of 4'-[methyl-(11)C]thiothymidine as a tumor proliferation imaging agent in mice.
- Comparison of VERSANT Hepatitis B Virus DNA 3.0 Assay with Digene Hybrid Capture II Hepatitis B Virus DNA Test in Relation to Clinical Status of Hepatitis B Virus.
- Serum anti-p53 antibodies as a useful marker for prognosis of gastric carcinoma.
- Microarray-based prediction of tumor response to neoadjuvant radiochemotherapy of patients with locally advanced rectal cancer.
- Cost-effectiveness of digital mammography breast cancer screening.
- MicroRNA Signature Predicts Survival and Relapse in Lung Cancer.
- Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays.
- Aberrant Splicing Caused by Single Nucleotide Polymorphism c.516G>T [Q172H], a Marker of CYP2B6*6, Is Responsible for Decreased Expression and Activity of CYP2B6 in Liver.
- Transcriptome profile of human colorectal adenomas.
- Self-Monitoring of Blood Glucose Before and After Medicare Expansion Among Medicare Beneficiaries With Diabetes Who Do Not Use Insulin.
- CHEK*1100delC Genotyping for Clinical Assessment of Breast Cancer Risk: Meta-Analyses of 26,000 Patient Cases and 27,000 Controls.
- Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling.
- Molecular imaging of the efficacy of heat shock protein 90 inhibitors in living subjects.
- Prostate-Specific Antigen Screening and Mortality from Prostate Cancer.
- Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells.
- Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patients.
- The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer.
- Molecular imaging of {alpha}v 3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA.
- Human Papillomavirus in Atypical Squamous Cervical Cytology: The Invader HPV Test as a New Screening Assay.